Sign inJoin waitlistJoin the waitlist

Karen Fink

Healthcare Provider · Baylor University Medical Center

Credentials: · · · ·

History

Baylor University Medical Center
Present

UT Southwestern Medical School Program
1995–1996
Neurology
University of Texas Southwestern Medical Center
1991–1994
MAYO CLINIC
1990–1991
Mayo Clinic School of Medicine
1985–1989

Research

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
JAMA · 2017 · 2,133 citations
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
JAMA · 2015 · 1,013 citations
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
Journal of Clinical Oncology · 2013 · 831 citations

Michael Prados
22 papers
Minesh Mehta
21 papers
Susan Chang
21 papers · 3 as a fellow
Timothy Cloughesy
19 papers
HR
H Robins
17 papers
PW
Patrick Wen
14 papers
LJ
Larry Junck
13 papers
David Schiff
12 papers
LD
Lisa DeAngelis
12 papers
HG
Harry Greenberg
10 papers
Howard Fine
10 papers
FL
Frank Lieberman
9 papers

Grants

Nabtc Member Institution Grant
National Cancer Institute · U01
Contact PI · $565.2K · Ut Southwestern Medical Center
1994–2003
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $30.1K · Ut Southwestern Medical Center
1997

Clinical trials

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Principal investigator · Completed · Phase 1
DNAtrix, Inc.
2014–2018
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Site PI · Unknown · Phase 1, Phase 2
Novacea
2006